SCHEMBL845488

SCHEMBL845488

CC(C)N(C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)N(C(C)C)C(C)C)cc2)cc1)C(C)C

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.48
CYP2C9 P11712 1/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
NPC1 O15118 1/20 0.47
PABPC1 P11940 1/20 0.47
ALDH1A1 P00352 3/20 0.47
HTT P42858 2/20 0.47
MAPK1 P28482 2/20 0.47
LMNA P02545 2/20 0.45
POLB P06746 1/20 0.45
KCNH2 Q12809 1/20 0.45
KDM4E B2RXH2 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845759 1.00 CYP2C19 (0.48) CYP2C19CYP2C9KMT2AMEN1NPC1
SCHEMBL845202 1.00 CYP2C19 (0.48) CYP2C19CYP2C9KMT2AMEN1NPC1
SCHEMBL845774 0.89 CYP2C19 (0.49) CYP2C19CYP2C9KMT2AMEN1NPC1
SCHEMBL844890 0.86 KCNH2 (0.51) CYP2C19CYP2C9KMT2AMEN1NPC1
SCHEMBL844894 0.86 CYP2C19 (0.55) CYP2C19CYP2C9KMT2AMEN1NPC1
SCHEMBL845203 0.86 CCR1 (0.47) CYP2C19CYP2C9KMT2AMEN1NPC1
SCHEMBL10119686 0.86 CYP2C9 (0.47) CYP2C19CYP2C9KMT2AMEN1NPC1
SCHEMBL845258 0.85 MAPK1 (0.60) CYP2C19CYP2C9KMT2AMEN1NPC1
SCHEMBL845245 0.83 PTPN1 (0.50) CYP2C19CYP2C9KMT2AMEN1NPC1
SCHEMBL844919 0.81 NPC1 (0.54) CYP2C19CYP2C9KMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed